Dr. Leung is an infectious diseases clinical pharmacist, and co-leads the Antimicrobial Stewardship Program (ASP) at St. Michael’s Hospital. Dr. Leung joined St. Michael’s Hospital in 2013, after completing her PGY1 clinical practice residency (UCSF), and PGY2/3 specialty residency training in infectious diseases and critical care (Northwestern Memorial Hospital, Rush Medical Center, Midwestern University/Chicago College of Pharmacy). She holds a Masters of Clinical Investigation (MSCI) from Northwestern University and Doctorate of Pharmacy from MCPHS-Boston.
Dr. Leung is a member of the Ontario COVID-19 Science Advisory Table’s Clinical Practice Guidelines working group. She coordinates the Infectious Diseases course at the University of Toronto, Leslie Dan Faculty of Pharmacy (PharmD for Pharmacists program). Dr. Leung serves as a member, and current chair of the Board of Pharmacotherapy Specialists (BPS) inaugural ID Specialty Council, which advises upon conferring specialty certification designation to qualified infectious diseases clinical pharmacists. Dr. Leung also serves as a peer reviewer for several pharmacy journals, and is an active member of the Society of Infectious Diseases Pharmacists (SIDP). She has also served as an invited panelist for the American College of Clinical Pharmacy (ACCP) Standards Setting Committee for Board Certified Critical Care Pharmacists (BCCCP). Her research interests include antimicrobial stewardship, optimizing pharmacokinetics/pharmacodynamics (PK/PD) for multi-drug resistant organisms, and enhancing microbiology antibiograms for clinical use.